HK:2269 Stock Latest News
PremiumRatingsWuXi Biologics: Strong Growth and Strategic Expansion Drive Buy Rating and Target Price Increase Wuxi Biologics Grants Over 25 Million Restricted Shares to Employees Wuxi Biologics Reports Strong 2024 Earnings Growth PremiumCompany AnnouncementsWuXi Biologics Reports Strong Growth and Future Prospects at Healthcare Conference WuXi Biologics Announces Hong Kong Office Relocation Wuxi Biologics Sells Vaccines Ireland Facility for $500M PremiumCompany AnnouncementsWuXi Biologics Acquires Full Ownership of WuXi Vaccines WuXi Biologics Announces 2024 Interim Results Call Wuxi Biologics Reports Mixed Mid-Year Financials